When a secondary drug is used to treat TB, it is typically addressing which form of TB?

When a secondary drug is used to treat TB, it is typically addressing which form of TB?

• A. Pulmonary TB
• B. Latent TB infection
• C. Extrapulmonary TB
• D. Multidrug-resistant TB

Answer: (C)

When an additional drug is added to TB treatment, the situation typically involves extrapulmonary TB—disease that has spread beyond the lungs to other tissues such as lymph nodes, meninges, bones, or organs. These sites can be harder for drugs to reach effectively, and treatment may require longer duration or different drugs to ensure complete eradication and to prevent relapse. The standard four-drug regimen effectively treats pulmonary TB, but extrapulmonary disease often needs this extra drug approach to address tissue penetration and site-specific considerations. Latent TB infection is treated differently with preventive therapy, and multidrug-resistant TB requires a distinct, second-line regimen rather than simply adding a secondary drug to the standard course.

When an additional drug is added to TB treatment, the situation typically involves extrapulmonary TB—disease that has spread beyond the lungs to other tissues such as lymph nodes, meninges, bones, or organs. These sites can be harder for drugs to reach effectively, and treatment may require longer duration or different drugs to ensure complete eradication and to prevent relapse. The standard four-drug regimen effectively treats pulmonary TB, but extrapulmonary disease often needs this extra drug approach to address tissue penetration and site-specific considerations. Latent TB infection is treated differently with preventive therapy, and multidrug-resistant TB requires a distinct, second-line regimen rather than simply adding a secondary drug to the standard course.